| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 13 |
| 1 | OMEPRAZOLE MAGNESIUM | 13 |
| 2 | OMEPRAZOLE | 12 |
| 3 | OLANZAPINE | 9 |
| 4 | OLANZAPINE PAMOATE | 9 |
| 5 | QUETIAPINE | 9 |
| 6 | ETANERCEPT | 8 |
| 7 | PREDNISOLONE | 8 |
| 8 | PREDNISOLONE ORAL | 8 |
| 9 | PREDNISOLONE ORAL SOLUTION | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LISOCABTAGENE MARALEUCEL | 1 | 0.0011 |
| 1 | TRIHEXYPHENIDYL HYDROCHLORIDE | 1 | 0.0010 |
| 2 | IDARUCIZUMAB | 1 | 0.0007 |
| 3 | TERBUTALINE SULFATE | 1 | 0.0005 |
| 4 | ANIFROLUMAB-FNIA | 1 | 0.0005 |
| 5 | RESMETIROM | 1 | 0.0004 |
| 6 | VUTRISIRAN | 1 | 0.0003 |
| 7 | BARICITINIB | 1 | 0.0003 |
| 8 | CLADRIBINE | 3 | 0.0003 |
| 9 | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 1 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 2 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 3 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 5 | Purine Antimetabolite [EPC] | 8 | 0.0001 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 6 | 0.0001 |
| 7 | Vitamin D Analog [EPC] | 1 | 0.0001 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 9 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |